🔗 Share this article

Treasury head Reeves has announced she is preparing "specific measures to address cost of living pressures" in next month's financial statement.

During an interview with the BBC, she emphasized that reducing price rises is a shared duty of both the administration and the Bank of England.

The UK's price growth is forecast to be the highest among the G7 industrialized countries this calendar year and next.

Potential Utility Cost Measures

It is understood the administration could intervene to reduce utility costs, for example by slashing the current 5% level of value-added tax charged on energy.

Another possibility is to cut some of the policy costs currently added to bills.

Fiscal Constraints and Expert Predictions

The government will receive the latest draft from the independent fiscal watchdog, the Office for Budget Responsibility, on the start of the week, which will show how much room there is for these actions.

The view from the majority of experts is that the Chancellor will have to announce tax increases or expenditure reductions in order to adhere to her declared fiscal targets.

Previously on the same day, calculations indicated there was a twenty-two billion pound gap for the Treasury chief to resolve, which is at the lower end of forecasts.

"There's a collective responsibility between the central bank and the administration to continue tackling some of the sources of inflation," Reeves told reporters in the US capital, at the conferences of the IMF and global financial institution.

Revenue Commitments and Global Issues

While a great deal of the focus has been on probable tax increases, the chancellor said the most recent data from the OBR had not changed her commitment to manifesto promises not to raise tax levels on earnings tax, sales tax or National Insurance.

She attributed an "uncertain world" with growing geopolitical and trade issues for the Budget tax moves, likely to be directed on those "wealthiest."

Global Economic Tensions

Referring to worries about the UK's economic relations with China she said: "The UK's national security invariably take priority."

Recent declaration by Chinese authorities to tighten trade restrictions on critical minerals and other resources that are essential for high-technology manufacturing led American leader Donald Trump to suggest an further 100% tariff on goods from China, raising the possibility of an full-scale commercial conflict between the two global powers.

The US Treasury Secretary described the Chinese move "economic coercion" and "a international production control attempt."

Asked about accepting the American proposal to join its conflict with the Asian nation, the Chancellor said she was "extremely troubled" by Chinese actions and encouraged the Chinese government "not to put up barriers and limit trade."

She said the action was "harmful for the global economy and generates additional challenges."

"It is my opinion there are fields where we should address Chinese policies, but there are also significant opportunities to trade with China's economy, including financial services and other sectors of the economy. We've got to get that equilibrium correct."

The Treasury chief also confirmed she was collaborating with international partners "regarding our own essential resources strategy, so that we are less reliant."

Health Service Medicine Pricing and Investment

The Chancellor also acknowledged that the price the NHS pays for pharmaceuticals could increase as a result of ongoing talks with the US government and its pharmaceutical firms, in exchange for lower tariffs and investment.

Some of the biggest global drug companies have said recently that they are either delaying or canceling operations in the UK, with several attributing the insufficient payments they are receiving.

Last month, the government science advisor said the cost the health service spends on medicines would must increase to prevent companies and pharmaceutical investment departing from the United Kingdom.

The Chancellor informed the BBC: "It has been observed because of the cost structure, that medical research, new drugs have not been offered in the United Kingdom in the way that they are in other European countries."

"We want to ensure that patients getting treatment from the National Health Service are can receive the top life-saving medicines in the globe. And so we are examining these issues, and... seeking to secure increased funding into Britain."